The South African Collaborative Surgical Outcomes Study (SACSOS)
Launched by SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY · Sep 17, 2021
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The South African Collaborative Surgical Outcomes Study (SACSOS) is a clinical trial aimed at improving the care patients receive before and after surgery. The study will use a digital health tool called the Perioperative Shared Health Record (PSHR) to collect important information about patients' recovery experiences. This tool will help doctors and patients work together by sharing data about how patients feel after surgery, including their quality of life and recovery progress. By gathering this information, the trial hopes to enhance the overall quality of surgical care.
To participate in this study, individuals need to be adults who are scheduled for any type of surgery at hospitals in South Africa. However, people who are unable to give their consent or who don’t have someone to represent them during follow-up cannot join the trial. While the study is not yet recruiting participants, those who do take part can expect to share their recovery experiences through questionnaires, which will help healthcare teams understand and improve patient care after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients presenting for any surgical procedure at South African hospitals during the specified study period.
- Exclusion Criteria:
- • Patients unable to provide consent to participation.
- • Patients whose legal guardian is unable to provide consent to participation (if applicable).
- • Patients unable to nominate next-of-kin, guardian of or a person of their choice, as their representative during follow-up.
About Sefako Makgatho Health Sciences University
Sefako Makgatho Health Sciences University (SMU) is a prominent institution dedicated to advancing health sciences education, research, and community service in South Africa. With a strong emphasis on interdisciplinary collaboration, SMU engages in innovative clinical trials aimed at addressing pressing health challenges. The university fosters a robust research environment supported by state-of-the-art facilities and a diverse pool of experts, ensuring the integration of cutting-edge scientific inquiry with practical healthcare solutions. Through its commitment to excellence, SMU plays a pivotal role in enhancing public health outcomes and contributing to the global health research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Bruce Biccard, PhD
Principal Investigator
University of Cape Town
Hyla-Louise Kluyts, DMed
Principal Investigator
Sefako Makgatho Health Sciences University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials